Breaking News
Investing Pro 0
New Year’s SALE: Up to 40% OFF InvestingPro+ CLAIM OFFER
Close

Ionis Pharmaceuticals Inc (IONS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Ionis Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.02 +0.64    +1.63%
27/01 - Closed. Currency in USD ( Disclaimer )
After Hours
39.22
-0.80
-2.00%
16:07:17 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 487,172
  • Bid/Ask: 39.70 / 40.32
  • Day's Range: 39.15 - 40.20
Ionis Pharma 40.02 +0.64 +1.63%

IONS Recent Sentiments

 
This page contains information on users’ sentiments for the Ionis Pharmaceuticals Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Jan 25, 2023 Fabrice Azoulay   39.89 +0.33%
Jan 19, 2023 Itzik Eliyahu   40.42 Jan 23, 2023 @ 39.96 -1.14%
Jan 06, 2023 DANAI XRISOXOIDOU   39.92 Jan 09, 2023 @ 39.61 +0.78%
Nov 30, 2022 Alexandre Bavastro   40.74 Dec 23, 2022 @ 38.16 -6.33%
Nov 10, 2022 Itzik Eliyahu   45.31 Nov 14, 2022 @ 44.59 -1.59%
Nov 01, 2022 Itzik Eliyahu   44.87 Nov 07, 2022 @ 41.27 -8.02%
Oct 28, 2022 Gianni Doro   44.52 Oct 31, 2022 @ 44.44 -0.18%
Oct 28, 2022 Itzik Eliyahu   44.43 Oct 31, 2022 @ 44.44 +0.02%
Oct 12, 2022 Itzik Eliyahu   45.84 Oct 17, 2022 @ 47.17 +2.90%
Oct 03, 2022 Freddy De Meersman   44.93 Oct 28, 2022 @ 44.61 -0.71%
Sep 07, 2022 Alexandre Bavastro   43.41 Sep 30, 2022 @ 44.23 +1.89%
Aug 10, 2022 ricardo fuster   45.44 Aug 15, 2022 @ 44.19 -2.75%
Aug 03, 2022 Alexandre Bavastro   42.60 Aug 26, 2022 @ 42.35 -0.59%
Aug 03, 2022 Alexandre Bavastro   42.60 Aug 26, 2022 @ 42.35 -0.59%
Jul 18, 2022 DANAI XRISOXOIDOU   40.00 Jul 25, 2022 @ 38.03 -4.93%
Jul 15, 2022 Евгений Емельянов   38.77 Aug 05, 2022 @ 45.70 +17.87%
Jul 06, 2022 Gianni Doro   37.26 Jul 11, 2022 @ 36.78 -1.29%
Jun 29, 2022 DANAI XRISOXOIDOU   37.95 Jul 04, 2022 @ 38.06 +0.29%
Jun 21, 2022 DANAI XRISOXOIDOU   37.77 Jun 27, 2022 @ 39.10 +3.52%
May 20, 2022 DANAI XRISOXOIDOU   39.38 May 23, 2022 @ 39.15 -0.58%
May 18, 2022 Mifs Games   38.38 Jun 10, 2022 @ 34.76 -9.43%
May 10, 2022 Pavel Galeev   34.12 Jun 03, 2022 @ 36.15 +5.95%
Apr 19, 2022 DANAI XRISOXOIDOU   41.25 Apr 25, 2022 @ 41.63 +0.92%
Mar 30, 2022 DANAI XRISOXOIDOU   35.79 Apr 04, 2022 @ 38.53 +7.66%
Mar 22, 2022 GINO CAMPANER   35.70 Mar 28, 2022 @ 35.69 -0.03%
Mar 22, 2022 DANAI XRISOXOIDOU   35.67 Mar 28, 2022 @ 35.69 +0.06%
Mar 14, 2022 DANAI XRISOXOIDOU   32.31 Mar 21, 2022 @ 35.20 +8.94%
Mar 08, 2022 DANAI XRISOXOIDOU   32.39 Mar 14, 2022 @ 32.34 -0.15%
Feb 28, 2022 Artur Dimaev   32.86 Mar 25, 2022 @ 36.67 +11.59%
Feb 17, 2022 nik nikols   32.65 Mar 11, 2022 @ 32.19 -1.41%
Feb 17, 2022 Abdo Khoury   32.79 Mar 11, 2022 @ 32.19 -1.83%
Feb 15, 2022 DANAI XRISOXOIDOU   32.80 Feb 21, 2022 @ 32.27 -1.62%
Feb 08, 2022 DANAI XRISOXOIDOU   32.29 Feb 14, 2022 @ 32.59 +0.93%
Feb 01, 2022 DANAI XRISOXOIDOU   31.04 Feb 07, 2022 @ 32.17 +3.64%
Jan 18, 2022 DANAI XRISOXOIDOU   30.99 Jan 24, 2022 @ 29.50 -4.81%
Jan 05, 2022 Laurens Sparrius   31.60 Jan 28, 2022 @ 31.68 +0.25%
Dec 21, 2021 DANAI XRISOXOIDOU   32.29 Dec 27, 2021 @ 31.71 -1.80%
Dec 17, 2021 DANAI XRISOXOIDOU   31.91 Dec 20, 2021 @ 32.57 +2.07%
Dec 10, 2021 Yoav Shoolman   29.84 Dec 31, 2021 @ 30.43 +1.98%
Dec 02, 2021 Ольга Кисель   25.80 Dec 06, 2021 @ 26.97 +4.53%
Nov 19, 2021 Aman Turgazy   31.94 Nov 24, 2021 @ 29.03 +9.11%
Nov 15, 2021 DANAI XRISOXOIDOU   32.99 Nov 22, 2021 @ 32.00 -3.00%
Oct 29, 2021 Владимир Кузьминых   31.59 Nov 19, 2021 @ 31.98 -1.23%
Oct 26, 2021 DANAI XRISOXOIDOU   30.05 Nov 01, 2021 @ 32.83 +9.25%
Oct 20, 2021 Gamika Premarathne   31.37 Oct 25, 2021 @ 30.11 +4.02%
Oct 19, 2021 Gianni Doro   30.15 Oct 25, 2021 @ 30.11 -0.13%
Oct 18, 2021 Назим Амиров   30.50 Nov 12, 2021 @ 32.70 +7.21%
Oct 18, 2021 Karan Bhutani   29.80 Nov 12, 2021 @ 32.70 -9.73%
Oct 18, 2021 faisal al farsi   30.01 Nov 12, 2021 @ 32.70 +8.96%
Oct 18, 2021 Mattia Silvestri   29.72 Nov 12, 2021 @ 32.70 -10.03%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IONS Comments

Write your thoughts about Ionis Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Tullio Bressanello
Tullio Bressanello Oct 01, 2021 10:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What’s about this stock? Any new therapies are coming out?
Crim Jamer
Crim Jamer Oct 01, 2021 10:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think shareholders needs a therapy now. BIIB / IONIS Tofersen (BIIB067) Phase 3 test did unsuccesful
Bobo Müller
Bobo Müller Jun 09, 2021 12:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Absolutely underrated stock. See you in ten years or this fall when the product in cooperation with Biogen comes out
Kurt Maxberry
Kurt Maxberry Jun 07, 2021 11:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Added 4000 at 34.4
Crim Jamer
Crim Jamer May 20, 2021 4:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice after market move!
Luke Sky
Luke Sky Apr 24, 2021 1:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Give the anti-corona spray from marinomed-biotech some VC and invest in a pharma company which is heading to the moon:https://www.investing.com/equities/marinomed-biotech-agStudies are proving that the patented method of marinomed prevents infection with all Corona varietis including mutants. It also prevents other virus infections. They have many patents.  Do some good and get rich
Crim Jamer
Crim Jamer Mar 22, 2021 5:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CARLSBAD, Calif., March 22, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced its partner, Roche, has decided to discontinue dosing in the Phase III GENERATION HD1 study of tominersen in manifest Huntington's disease (HD). The decision was based on the results of a pre-planned review of data from the Phase III study conducted by an unblinded Independent Data Monitoring Committee (iDMC). While there were no new or emerging safety signals identified for tominersen, the iDMC made its recommendation based on the investigational therapy's potential benefit/risk profile for study participants. Participants will continue to be followed for safety and clinical outcomes.
Sean Landolt
Sean Landolt Sep 30, 2020 3:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this stock doesn't know what a green day looks like.
형진 조
형진 조 Sep 14, 2019 1:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ㅜㅜ~
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email